Abstract
Anatomic segmentectomy was first described in 1939 for the treatment of benign lung conditions (1). The usual indications also include metastatic disease to the lung when ta parenchyma-sparing procedure is anticipated Nevertheless, anatomic pulmonary segmentectomy has been demonstrated to be effective in the resection of small primary lung cancers (2,3). Recently there has been a renewed interest in the use of anatomic segmentectomy, especially for patients unable to tolerate lobectomy because of poor cardiopulmonary function or severe comorbidities. Several recently published studies have shown that segmentectomy can be performed safely without compromising oncologic results (3-6).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
